Lilian van Wagensveld

Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers

Tom Van Nyen, Mélanie Planque, Lilian van Wagensveld et al. · Nature Communications · 2022 · 42 citations · Full text

Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a “real-life setting”

Lilian van Wagensveld, Olivier Colomban, Maaike A. van der Aa et al. · Journal of Gynecologic Oncology · 2024 · 15 citations · Full text

Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer

Lilian van Wagensveld, Juliette O. A. M. van Baal, Maite Timmermans et al. · Cancers · 2022 · 14 citations · Full text

847P The prognostic value of chemosensitivity, estimated by the modeled CA-125 KELIM, in ovarian cancer patients treated with neo-adjuvant chemotherapy in the Netherlands

Lilian van Wagensveld, Olivier Colomban, Maaike A. van der Aa et al. · Annals of Oncology · 2020 · 13 citations

Medicine, Cancer Management, Metronomic Therapy +9

Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era

Benoît You, Lilian van Wagensveld, Michel Tod et al. · British Journal of Cancer · 2022 · 13 citations · Full text